Details of the Drug Reposition

General Information of This Drug (ID: DM6L5TR)

Drug Name
EGEN-001   DM6L5TR

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Peritoneal cancer DISYX23I 2C51.Z Phase 2 [1]
Ovarian cancer DISZJHAP 2C73 Phase 2 [1]
Fallopian tube cancer DISXHWCS 2C74 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01118052) EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer. U.S. National Institutes ofHealth.